Tech Company Financing Transactions
Agalimmune Funding Round
Animatrix Finance and Loxbridge Research participated in a funding round for Agalimmune. This venture round was announced on 6/5/2014.
Transaction Overview
Company Name
Announced On
6/5/2014
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Loxbridge Research (Charles Roberts)
Proceeds Purpose
The investment will be used to fund Agalimmune's research into combination therapy with immune checkpoint inhibitors such as the CTLA-4, PD-1, and PD-L1 classes of compounds, as part of its supportive preclinical work packages.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2875 Michelle Dr. 300
Irvine, CA 92606
USA
Irvine, CA 92606
USA
Phone
Undisclosed
Website
Email Address
Overview
Agalimmune is a biopharmaceutical company with an innovative anti-cancer technology for the treatment of patients with solid tumors.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mike Westby
Chief Financial Officer
Stuart Lawson
Chief Operating Officer
Graham Griffiths
Browse more venture capital transactions:
Prev: 6/5/2014: Dinner Lab venture capital transaction
Next: 6/5/2014: NovaSom venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs